Xvivo Perfusion AB (LTS:0RKL) Dividends per Share : kr0.00 (TTM As of Sep. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Xvivo Perfusion AB Dividends per Share?

Xvivo Perfusion AB's dividends per share for the three months ended in Sep. 2024 was kr0.00. Its dividends per share for the trailing twelve months (TTM) ended in Sep. 2024 was kr0.00. Its Dividend Payout Ratio for the three months ended in Sep. 2024 was 0.00. As of today, Xvivo Perfusion AB's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Xvivo Perfusion AB Dividends per Share Historical Data

The historical data trend for Xvivo Perfusion AB's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xvivo Perfusion AB Dividends per Share Chart

Xvivo Perfusion AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dividends per Share

Get a 7-Day Free Trial

Xvivo Perfusion AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Dividends per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Xvivo Perfusion AB's Dividends per Share

For the Medical Devices subindustry, Xvivo Perfusion AB's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Xvivo Perfusion AB's Dividend Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xvivo Perfusion AB's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Xvivo Perfusion AB's Dividend Yield % falls into.

Xvivo Perfusion AB Dividends per Share Calculation

Dividends paid to per common share.

Xvivo Perfusion AB (LTS:0RKL) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Xvivo Perfusion AB's Dividend Payout Ratio for the quarter that ended in Sep. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Sep. 2024 )	/	EPS without NRI (Q: Sep. 2024 )
	=	0	/	2.71
	=	0.00

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Xvivo Perfusion AB Dividends per Share Related Terms

Thank you for viewing the detailed overview of Xvivo Perfusion AB's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Xvivo Perfusion AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xvivo Perfusion AB (LTS:0RKL) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

XVIPF:USA XVIVO:Sweden XVIVOs:UK 3XV:Germany

Address

Gemenskapens gata 9, Molndal, SWE, SE-431 53

Website

https://www.xvivoperfusion.com

Xvivo Perfusion AB is a medical technology company dedicated to extending the life of all major organs so transplant teams around the world can save more lives. Its solutions allow clinicians and researchers to push the boundaries of transplantation medicine. It operates in three segments namely, Thoracic: Sales of lung and heart transplant products, Abdominal: Sales of liver and kidney transplant products. Services: Revenue from sales of services in organ recovery (carried out by subsidiary STAR Teams Inc.). The majority of revenue is derived from the Thoracic segment. Geographically, the majority is from the United States.

Xvivo Perfusion AB Headlines

No Headlines